An exclusive, invitation-only gathering taking place on Thursday October 23, 2025 in New York City.
The event will convene a select group of investors, early-stage longevity biotech companies, and thought leaders shaping the future of healthspan innovation.
“Eos SENOLTYIX’s Novel MitoXcel™ Geropeptides Demonstrate Features of Safe and Effective Gerotherapeutics “
Presenter: Kevin Slawin, M.D., Founder and CEO
Member of the Longevity Biotechnology Association
About the Longevity Biotechnology Association:
The Longevity Biotechnology Association (LBA) is a 501c3 non-profit organization uniting the community advancing science-based approaches to extend healthy human lifespan. Founded by pioneers in the field, LBA brings together early-stage companies, seasoned investors, and world-class researchers to build a credible, collaborative ecosystem around longevity biotech.”
